Ikezono Yu 池園友

… Alternative Names

池園友イケゾノユウ

Less

Researcher Number	10461419
Affiliation (Current)	2025: 久留米大学, 医学部, 助教
Affiliation (based on the past Project Information) *help	2015 – 2017: 久留米大学, 医学部, 助教
Review Section/Research Field	Principal Investigator Gastroenterology Except Principal Investigator Gastroenterology
Keywords	Principal Investigator 癌幹細胞 / 神経内分泌腫瘍 / EMT / SLUG / FAK / NET / DCLK1 Except Principal Investigator 細胞療法 / 肝再生 / 肝硬変 / iPS細胞 / ペプチドハイドロゲル

Fundamental research for the development of an efficient hepatic regenerative cell therapy using self-assembling peptide hydrogel
- Principal Investigator
  
  Nakamura Toru
- Project Period (FY)
  2015 – 2017
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Gastroenterology
- Research Institution
  Kurume University
DCLK1 regulates stemness feature in neuroendocrine tumors.Principal Investigator
- Principal Investigator
  
  Ikezono Yu
- Project Period (FY)
  2015 – 2016
- Research Category
  
  Grant-in-Aid for Young Scientists (B)
- Research Field
  
  Gastroenterology
- Research Institution
  Kurume University

All 2017 2016 2015

All Journal Article Presentation

[Journal Article] Pancreatic Neuroendocrine Tumors and EMT Behavior Are Driven by the CSC Marker DCLK12017
- Author(s)
  Yu Ikezono
- Journal Title
  
  Molecular Cancer Research
  
  Volume: 不明 Issue: 6 Pages: 744-752
- DOI
  10.1158/1541-7786.mcr-16-0285
- Peer Reviewed / Acknowledgement Compliant / Open Access
- Data Source
  KAKENHI-PROJECT-15K19355, KAKENHI-PROJECT-17K08776
[Journal Article] Ex vivo expansion of circulating CD34+ cells enhances the regenerative effect on rat liver cirrhosis2016
- Author(s)
  Toru Nakamura, Hironori Koga, Hideki Iwamoto, Victor Tsutsumi, Yasuko Imamura, Masako Naitou, Atsutaka Masuda, Yu Ikezono, Mitsuhiko Abe, Fumitaka Wada, Takahiko Sakaue, Takato Ueno, Masaaki Ii, Cantas Alev, Atsuhiko Kawamoto, Takayuki Asahara, Takuji Torimura
- Journal Title
  
  Molecular Therapy - Methods & Clinical Development
  
  Volume: 3 Pages: 1-13
- DOI
  10.1038/mtm.2016.25
- Peer Reviewed / Acknowledgement Compliant / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-15K09030, KAKENHI-PROJECT-26461025
[Journal Article] High expression of the putative cancer stem cell marker, DCLK1, in rectal neuroendocrine tumors.2015
- Author(s)
  Ikezono YU, Koga H, Abe M, Akiba J, Kawahara A, Yoshida T, Nakamura T, Iwamoto H, Yano H, Kage M, Sata M, Tsuruta O, Torimura T.
- Journal Title
  
  Oncology Letters
  
  Volume: 10 Issue: 4 Pages: 2015-2020
- DOI
  10.3892/ol.2015.3513
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-26461025, KAKENHI-PROJECT-15K19355
[Presentation] 培養CD34+細胞を用いた肝硬変に対する肝再生治療2016
- Author(s)
  中村徹、古賀浩徳、増田篤高、岩本英希、池園友、和田史孝、阪上尊彦、上野隆登、鳥村拓司
- Organizer
  第102回日本消化器病学会総会
- Place of Presentation
  東京
- Year and Date
  2016-04-21
- Data Source
  KAKENHI-PROJECT-15K09030
[Presentation] 培養CD34+細胞を用いた細胞移植療法による肝線維化改善促進の機序解明2016
- Author(s)
  中村徹、古賀浩徳、増田篤高、岩本英希、池園友、和田史孝、阪上尊彦、上野隆登、鳥村拓司
- Organizer
  第52回日本肝臓学会総会
- Place of Presentation
  幕張
- Year and Date
  2016-05-19
- Data Source
  KAKENHI-PROJECT-15K09030
[Presentation] Long term outcome of autologous G-CSF mobilized PB-CD34+ cell therapy in patients with decompensated liver cirrhosis2016
- Author(s)
  Toru Nakamura, Hironori Koga, Hideki Iwamoto, Atsutaka Masuda, Yu Ikezono, Fumitaka Wada, Takahiko Sakaue, Toshimitsu Tanaka, Mitsuhiko Abe, Takato Ueno, Takuji Torimura
- Organizer
  67th AMERICAN ASSOCIATION FOR THE STUDY OF LIVER DISEASES
- Place of Presentation
  ボストン
- Year and Date
  2016-11-11
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-15K09030
[Presentation] 膵神経内分泌腫瘍において幹細胞マーカーDCLK1はTyr925FAKを介し、腫瘍増殖・遊走を促進させる2016
- Author(s)
  池園　友
- Organizer
  日本癌学会学術総会
- Place of Presentation
  横浜
- Year and Date
  2016-10-06
- Data Source
  KAKENHI-PROJECT-15K19355
[Presentation] DCLK1 promotes tumor growth and invasion through Slug-mediated epithelial-mesenchymal transition in pancreatic neuroendocrine tumors2016
- Author(s)
  Yu Ikezono
- Organizer
  AACR2016
- Place of Presentation
  New Orleans, Louisiana, USA
- Year and Date
  2016-04-16
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-15K19355
[Presentation] 培養CD34+細胞を用いた免疫不全ラット肝硬変モデルに対する細胞療法の肝線維化改善促進の機序解明2016
- Author(s)
  中村徹、古賀浩徳、増田篤高、岩本英希、池園友、和田史孝、阪上尊彦、田中俊光、上野隆登、鳥村拓司
- Organizer
  第48回日本臨床分子形態学会総会
- Place of Presentation
  熊本
- Year and Date
  2016-09-23
- Data Source
  KAKENHI-PROJECT-15K09030
[Presentation] 膵神経内分泌腫瘍における癌幹細胞マーカーDclk1の機能解析2015
- Author(s)
  池園　友
- Organizer
  JDDW2015
- Place of Presentation
  東京
- Year and Date
  2015-10-08
- Data Source
  KAKENHI-PROJECT-15K19355
[Presentation] The putative cancer stem cell marker DCLK1 is highly expressed in pancreatic neuroendocrine tumors and induces epithelial-mesenchymal transition2015
- Author(s)
  Yu Ikezono
- Organizer
  UEGW2015
- Place of Presentation
  Carrer del Foc, 35, Barcelona, Spain
- Year and Date
  2015-10-24
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-15K19355

1. Nakamura Toru (30341332)

# of Collaborated Projects: 1 results

# of Collaborated Products: 5 results
2. 古賀浩徳 (90268855)

# of Collaborated Projects: 1 results

# of Collaborated Products: 6 results
3. 増田篤高 (40647872)

# of Collaborated Projects: 1 results

# of Collaborated Products: 5 results

Ikezono Yu 池園 友

池園 友 イケゾノ ユウ

Research Projects

Research Products

Co-Researchers

Fundamental research for the development of an efficient hepatic regenerative cell therapy using self-assembling peptide hydrogel

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

DCLK1 regulates stemness feature in neuroendocrine tumors.Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Journal Article] Pancreatic Neuroendocrine Tumors and EMT Behavior Are Driven by the CSC Marker DCLK12017

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Ex vivo expansion of circulating CD34+ cells enhances the regenerative effect on rat liver cirrhosis2016

Author(s)

Journal Title

DOI

Data Source

[Journal Article] High expression of the putative cancer stem cell marker, DCLK1, in rectal neuroendocrine tumors.2015

Author(s)

Journal Title

DOI

Data Source

[Presentation] 培養CD34+細胞を用いた肝硬変に対する肝再生治療2016

Author(s)

Organizer

Place of Presentation

Year and Date

Data Source

[Presentation] 培養CD34+細胞を用いた細胞移植療法による肝線維化改善促進の機序解明2016

Author(s)

Organizer

Place of Presentation

Year and Date

Data Source

[Presentation] Long term outcome of autologous G-CSF mobilized PB-CD34+ cell therapy in patients with decompensated liver cirrhosis2016

Author(s)

Organizer

Place of Presentation

Year and Date

Data Source

[Presentation] 膵神経内分泌腫瘍において幹細胞マーカーDCLK1はTyr925FAKを介し、腫瘍増殖・遊走を促進させる2016

Author(s)

Organizer

Place of Presentation

Year and Date

Data Source

[Presentation] DCLK1 promotes tumor growth and invasion through Slug-mediated epithelial-mesenchymal transition in pancreatic neuroendocrine tumors2016

Author(s)

Organizer

Place of Presentation

Year and Date

Data Source

[Presentation] 培養CD34+細胞を用いた免疫不全ラット肝硬変モデルに対する細胞療法の肝線維化改善促進の機序解明2016

Author(s)

Organizer

Place of Presentation

Year and Date

Data Source

[Presentation] 膵神経内分泌腫瘍における癌幹細胞マーカーDclk1の機能解析2015

Author(s)

Organizer

Place of Presentation

Year and Date

Data Source

[Presentation] The putative cancer stem cell marker DCLK1 is highly expressed in pancreatic neuroendocrine tumors and induces epithelial-mesenchymal transition2015

Author(s)

Organizer

Place of Presentation

Year and Date

Data Source

Ikezono Yu 池園友

池園友イケゾノユウ